MET and pancreatic neoplasm: For example, it was found that silencing RON in pancreatic cancer cell lines leads to upregulation of c-Met expression and activity (61), whilst another study has demonstrated that oncogenic addition to c-Met requires co-expression of constitutively activated RON that was dependent on transphosphorylation by c-Met (23).